Fujifilm SonoSite inks clinician training deal
Ultrasound developer Fujifilm SonoSite has entered into an agreement with Intelligent...Read more on AuntMinnie.comRelated Reading: Fujifilm SonoSite teams with AI developer Fujifilm SonoSite inks AI deal with Partners HealthCare Fujifilm SonoSite launches medical informatics software Fujifilm SonoSite releases new iViz ultrasound transducers Fujifilm SonoSite names new CEO, COO
Publication date: Available online 28 March 2020Source: Journal of Clinical NeuroscienceAuthor(s): Tugba Ozsoy-Unubol, Yeliz Bahar-Ozdemir, Ilker Yagci
Authors: Zhang Y, Bi L, Hu Z, Cao W, Zhuang D Abstract It has been found that>90% of oral cancer patients suffer from squamous cell carcinoma (SCC). The 5-year survival rate of SCC is ~50%, despite the availability of different treatments. Sonodynamic therapy (SDT) has been developed as a novel therapy for cancer, resisting bacterial infection and inhibiting atherosclerotic plaque progression. The present study investigated the efficacy of hematoporphyrin monomethyl ether (HMME)-mediated SDT on the A-253 epidermoid cancer cell line. The cytotoxicity of HMME and the survival rate of cells following SDT were exami...
The diagnosis of congenital M üllerian anomalies in children and adolescents has historically relied on imaging modalities including MRI, ultrasound and fluoroscopy. For patients at higher risk for these anomalies, there may be an opportunity to perform diagnostic hysteroscopy with concomitant endoscopy to improve understanding of their gynecologic anatomy and to plan for future imaging, procedures or care. However, there remains a paucity of data looking specifically at the role and safety profile of hysteroscopy for the diagnosis of Müllerian anomalies in peri-menarchal patients.
This work has been previously published.
20-30% of women with Mullerian anomalies have coexistent renal anomalies and obtaining renal ultrasounds after a new diagnosis of Mullerian anomaly has become common practice among gynecologists. However, there are yet no formal recommendations to screen patients with a known congenital renal anomaly for a coexisting Mullerian anomaly. Friedman et al has proposed screening guidelines including pelvic ultrasound prior to menarche. The primary aim of this study is to provide data to support the proposed screening recommendations set forth by that prior review.
To determine if transvaginal ultrasound can be used as a reliable alternative to uterine sounding for measurement of uterine length prior to intrauterine device placement.
Conclusions: Asymptomatic adductor and pubic abnormalities on MRI are frequently present but vary greatly between selected studies. No exact conclusions can be drawn about the prevalence of asymptomatic adductor or pubic findings on MRI due to high heterogeneity between studies. Furthermore, the one article about ultrasound was not enough to draw conclusions for ultrasound findings. It is nonetheless clear that clinicians should be careful to make diagnoses purely based on radiologic findings. A thorough clinical examination and individual interpretation conducted by the clinician remains indispensable. PMID: 32213080 ...
Publication date: 28 March 2020Source: New Scientist, Volume 245, Issue 3275Author(s): Jason Arunn Murugesu
ConclusionPre-clinical experiments demonstrated promising results for in-situ confirmation of lesion locations in prostates using Raman spectroscopy, both in phantoms and human ex-vivo prostate tissue, which is required for integration in HDR brachytherapy procedures.